When now taking only pits into account, we found that a specific CatK inhibitor decreased the resorption depths by only 14% in 8 BC-OC preparations, and by 12% in 8 BM-OC preparations (Figure 3b). The gene discussed is BGLAP; the disease is breast cancer.